LUPIN
Back to Cashflow Statement
|
LUPIN Last 5 Year Cash Flow from Operating Activities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Cash Flow from Operating Activities | ₹7,335 Cr | ₹3,000 Cr | ₹3,648 Cr | ₹1,897 Cr | ₹367 Cr |
What is the latest Cash Flow from Operating Activities ratio of LUPIN ?
| Year | Cash Flow from Operating Activities |
|---|---|
| Mar2026 | ₹7,335 Cr |
| Mar2025 | ₹3,000 Cr |
| Mar2024 | ₹3,648 Cr |
| Mar2023 | ₹1,897 Cr |
| Mar2022 | ₹367 Cr |
How is Cash Flow from Operating Activities of LUPIN Trending?
| Years | Cash Flow from Operating Activities | % Change | |
|---|---|---|---|
| Mar2026 | ₹7,335 Cr | 144.49 | |
| Mar2025 | ₹3,000 Cr | -17.77 | |
| Mar2024 | ₹3,648 Cr | 92.30 | |
| Mar2023 | ₹1,897 Cr | 416.52 | |
| Mar2022 | ₹367 Cr | - | |
Compare Cash Flow from Operating Activities of peers of LUPIN
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| LUPIN | ₹101,498.4 Cr | -1.8% | -11.7% | 14.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹455,394.0 Cr | -2.3% | -3.3% | 15.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹226,312.0 Cr | 0.3% | 16.3% | 44.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹190,678.0 Cr | 2.8% | -0.5% | 37.1% | Stock Analytics | |
| CIPLA | ₹114,392.0 Cr | -3.1% | -1.2% | -5.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹97,740.5 Cr | -2.9% | -3% | -3.3% | Stock Analytics | |
LUPIN Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| LUPIN | -1.8% |
-11.7% |
14.5% |
| SENSEX | -1.4% |
-1% |
-4.6% |
You may also like the below Video Courses